S
30.50
0.79 (2.66%)
| 前收盘价格 | 29.71 |
| 收盘价格 | 30.02 |
| 成交量 | 2,272,529 |
| 平均成交量 (3个月) | 2,552,512 |
| 市值 | 2,931,881,472 |
| 价格/销量 (P/S) | 13.14 |
| 股市价格/股市净资产 (P/B) | 14.50 |
| 52周波幅 | |
| 利润日期 | 14 Nov 2025 |
| 稀释每股收益 (EPS TTM) | -2.55 |
| 总债务/股东权益 (D/E MRQ) | 20.22% |
| 流动比率 (MRQ) | 10.25 |
| 营业现金流 (OCF TTM) | -229.84 M |
| 杠杆自由现金流 (LFCF TTM) | -134.32 M |
| 资产报酬率 (ROA TTM) | -50.15% |
| 股东权益报酬率 (ROE TTM) | -106.71% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 混合的 |
| Biotechnology (全球的) | 混合的 | 混合的 | |
| 股票 | Scholar Rock Holding Corporatio | 看涨 | 看涨 |
AIStockmoo 评分
0.1
| 分析师共识 | 3.0 |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | -0.5 |
| 平均 | 0.13 |
|
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Core |
| 内部持股比例 | 4.35% |
| 机构持股比例 | 118.63% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 53.00 (B of A Securities, 73.77%) | 购买 |
| 中 | 45.00 (47.54%) | |
| 低 | 44.00 (Truist Securities, 44.26%) | 购买 |
| 44.00 (Barclays, 44.26%) | 购买 | |
| 44.00 (HC Wainwright & Co., 44.26%) | 购买 | |
| 平均值 | 47.29 (55.05%) | |
| 总计 | 7 购买 | |
| 平均价格@调整类型 | 33.73 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Truist Securities | 20 Oct 2025 | 44.00 (44.26%) | 购买 | 27.92 |
| B of A Securities | 09 Oct 2025 | 53.00 (73.77%) | 购买 | 40.99 |
| Barclays | 24 Sep 2025 | 44.00 (44.26%) | 购买 | 33.72 |
| 17 Sep 2025 | 45.00 (47.54%) | 购买 | 31.95 | |
| Piper Sandler | 24 Sep 2025 | 51.00 (67.21%) | 购买 | 33.72 |
| HC Wainwright & Co. | 23 Sep 2025 | 44.00 (44.26%) | 购买 | 33.75 |
| Jefferies | 21 Aug 2025 | 50.00 (63.93%) | 购买 | 34.59 |
| BMO Capital | 07 Aug 2025 | 45.00 (47.54%) | 购买 | 31.40 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合